Gastric Balloon Market to Reach US$ 152.1 Mn in 2027

1
Gastric Balloon Market
Gastric Balloon Market to 2027 - Global Analysis
and Forecasts By Product (Single Gastric
Balloons, Dual Gastric Balloons and Triple
Gastric Balloons), Filling Material (Saline
Filled and Gas Filled), End User (Bariatric
Surgeons, Gastrointestinal Endoscopists,
Nutritionists, Aesthetic Practitioners, and Other
End Users), and Geography
2
Market Scope
Gastric Balloon Market

• The global gastric balloon market accounted to
  US 62.9 Mn in 2017 and is expected to grow at a
  CAGR of 9.7 during the forecast period 2018 -
  2027, to account to US 152.1 Mn by 2027.
• Asia-Pacific was the leading geographic Gastric
  Balloon Market and it is anticipated to be the
  highest revenue contributor throughout the
  forecast period. Asia is well known across the
  world for the dynamic market nature and robust
  growth capabilities.

3
Market Segments
Gastric Balloon Market
4
Factors Contributing to Market Growth
Gastric Balloon Market

• Rise in the cases of obesity across the globe is
  expected to boost the market growth over the
  years
• Rising Preference for Minimally Invasive Methods
• Product Insights
• The global gastric balloon market by product was
  led by single gastric balloon segment. The single
  gastric balloons, is further sub-segmented into,
  Elipse gastric balloons, Orbera gastric balloons
  and other single gastric balloons. In 2018, the
  single gastric balloon segment held a largest
  market share of 89.0 of the gastric balloon
  market, by product. This segment is also expected
  to dominate the market in 2027 owing to its
  property of being implanted more easily as
  decreased rate of complications. In addition to
  larger share, the segment is anticipated to
  witness the fastest growth rate during the
  forecast period, 2019 to 2027.

5
Gastric Balloon Market
Strategic Insights
Approvals and agreements were observed as the
most adopted strategy in global gastric balloon
industry. Few of the recent product launch and
collaboration are listed below 2018 In April,
2018, Apollo received approval from the Saudi
Food and Drug Authority (SFDA) for the ORBERA365
Managed Weight Loss System. This approval enables
the reach of ORBERA365 into the largest bariatric
market in the Middle East with over 15,000
procedures performed per year. 2017 In
November, 2017, Obalon and Sono Bello entered an
agreement. Through the agreement the Obalon
Balloon System would be used for non-surgical
weight loss in Sono Bello centers across the
US. 2015 In December 2015, Allurion received a
CE mark allowing sale of the product in the
European Union. The product has been made
available in the weight loss centers in France,
Italy and the United Kingdom.
For more details, get sample PDF copy
https//www.theinsightpartners.com/sample/TIPRE000
03016/
6
Leading Players
Gastric Balloon Market

• Allurion Technologies Inc.
• Apollo Endosurgery, Inc.
• ENDALIS
• Helioscopie Medical Implants
• LEXEL SRL
• MEDSIL
• Obalon Therapeutics, Inc.
• ReShape Lifesciences, Inc.
• Silimed
• Spatz FGIA, Inc.

7

A report titled Gastric Balloon Market -
Opportunities and Forecasts, 2018 2027 has
been recently published by The Insight Partners.
The report makes close observations of pipeline
structure for end-to-end market around the world.
It makes an in-depth analysis of current trends,
drivers,
and restraining factors that affect financial rati
os relevant to the industry.
Company profiles for key vendors in business
builds a comprehensive picture of profitable
opportunities from stakeholders perspective.

To know more about the Specialty Hospitals Market
- Opportunities and Forecasts, 2018 2027 report
https//www.theinsightpartners.com/reports/gastric
-balloon-market
Follow us on
Thank You